Table 2.
Number of haemodynamic events of interest for oxytocin and carbetocin in VigiBase, the World Health Organization’s database for individual case safety reports
| Outcome of interest | Oxytocin (N = 11,258) | Carbetocin (N = 374) | ||
|---|---|---|---|---|
| Occurrence (%)* | Serious (%)† | Occurrence (%)* | Serious (%)† | |
| Hypotension | 223 (2.0) | 81 (36.3) | 19 (5.1) | 10 (52.6) |
| Hypertension | 80 (0.7) | 41 (51.2) | 9 (2.4) | 5 (55.6) |
| Bradycardia | 91 (0.8) | 47 (51.6) | 6 (1.6) | 4 (66.7) |
| Tachycardia | 231 (2.1) | 100 (43.3) | 21 (5.6) | 11 (52.4) |
“Serious” equals whether medical intervention was required
*The percentage refers to all reports of the respective drug
†The percentage refers to the respective outcome and the respective drug